-
Predicting phase separation of cancer-causing fusion oncoproteins with machine learning
09/28/2023
See how machine learning was used to gain insight into condensation behavior and oncogenic mechanisms of fusion oncoproteins.
-
St. Jude refines definition and hones treatment of hyperdiploid leukemia
09/20/2023
Hyperdiploid B-cell acute lymphoblastic leukemia has evaded a consensus definition. Find the definitions that best correlated with better patient outcomes.
-
Specialized T cells in the brain slow progression of Alzheimer’s disease
09/07/2023
T cells can slow Alzheimer’s disease progression in a model system. Find how the neuro-immune study may be the future of neurodegenerative disease research.
-
St. Jude Children’s Research Hospital announces more than $50 million in funding for employee-generated transformational projects
08/30/2023
St. Jude has announced funding for employee-generated ideas. Find out about the approved projects
-
St. Jude shows cancer resistance protein can have its cake and eat it too
08/18/2023
See how one protein responsible for chemotherapy resistance functions and how we can prevent future drug resistance to improve treatment
-
Immune cells present long before infection predict flu symptoms
08/17/2023
Who will get sick from influenza infection has long been a mystery. Learn how immune cells may predict susceptibility to symptoms long before flu infection.
-
Mutation accessibility fuels influenza evolution
07/28/2023
See how a new model developed by St. Jude scientists looking at influenza evolution can predict future virus mutations.
-
Pediatric Early Warning Systems save lives in Latin American hospitals
07/08/2023
Learn how Pediatric Early Warning Systems save the lives of children with cancer in Latin America by identifying early when they are in need of supportive care.
-
Pediatric hepatoblastoma model hints at DNA damage repair pathway for novel therapeutics
07/07/2023
See how creating a new research model to study hepatoblastoma (liver cancer) gave St. Jude scientists clues into potential therapeutic targets
-
Immune and tumor cell “tug-of-war” controls anti-cancer activity
07/05/2023
Cancer cells & the immune cells that activate the anti-cancer response compete over the nutrient glutamine. Discover how it may improve cancer therapies.
Explore more research news
More Research News
-
Scientific Report 2023
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.